| 注册
首页|期刊导航|中成药|固肾安胎丸联合低分子肝素干预复发性流产妇女血栓前状态的疗效

固肾安胎丸联合低分子肝素干预复发性流产妇女血栓前状态的疗效

韩宁 许雅娟

中成药2017,Vol.39Issue(12):2481-2484,4.
中成药2017,Vol.39Issue(12):2481-2484,4.DOI:10.3969/j.issn.1001-1528.2017.12.007

固肾安胎丸联合低分子肝素干预复发性流产妇女血栓前状态的疗效

Gushen Antai Pills combined with low-molecular-weight heparin treating prethrombotic state of women with recurrent spontaneous abortion

韩宁 1许雅娟1

作者信息

  • 1. 郑州大学第三附属医院产科,河南郑州450052
  • 折叠

摘要

Abstract

AIM To observe the clinical effects of Gushen Antai Pills (Polygoni multiflori Radix,Rehmanniae Radix,Cistanches Herba,etc.) combined with low-molecular-weight heparin (LMWH) in treating women with recurrent spontaneous abortion (RSA) due to coagulation disorder (prethrombotic state,PTS).METHODS One hundred and twenty-six cases of RSA patients in PTS were randomly assigned to observation group and control group for the treatment of either LMWH combined with Gushen Antai Pills or LMWH.The trial went on during the first twenty weeks of pregnancy.Investigations on total treatment efficiency,coagulation-fibrinolysis indicator levels before and after treatment were conducted,and results of follow-ups were compared as well.RESULTS The total effective rate of 73.0% in the control group and 87.3% in the observation group displayed a significant difference (P < 0.05).Although the levels of fibrinogen (FIB),D-dimer (D-D) and plasminogen activator inhibitorl (PAIl) were significantly improved (P < 0.05) after the treatment,the observation group was found to be significantly better in performance than the control group (P < 0.05).The live birth rate of 69.8% in the control group and 85.7% in the observation group also showed to be a significant difference (P < 0.05).CONCLUSION Gushen Antai Pills combined with LMWH can improve the thrombotic state and bring forth a higher live birth rate in patients with RSA.

关键词

固肾安胎丸/低分子肝素/复发性流产/血栓前状态

Key words

Gushen Antai Pills/low-molecular-weight heparin/recurrent spontaneous abortion/prethrombotic state

分类

医药卫生

引用本文复制引用

韩宁,许雅娟..固肾安胎丸联合低分子肝素干预复发性流产妇女血栓前状态的疗效[J].中成药,2017,39(12):2481-2484,4.

基金项目

常州四药临床药学科研基金(CZSYJJ16037) (CZSYJJ16037)

中成药

OA北大核心CSCDCSTPCD

1001-1528

访问量1
|
下载量0
段落导航相关论文